These results highlighted the inhibition of lncRNA DLX6-AS1 could suppress tumorigenesis and tumor growth of LCSCs in vivo by suppressing the STAT3 signaling pathway after increasing CADM1. This evidence concerns the gene STAT3 and neoplasm.